Li H - Search Results

1

A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma.

Yu H, Fu Y, Tang Z, Jiang L, Qu C, Li H, Tan Z, Shu D, Peng Y, Liu S. Yu H, et al. Among authors: li h. Aging (Albany NY). 2022 Jan 27;14(2):989-1013. doi: 10.18632/aging.203855. Epub 2022 Jan 27. Aging (Albany NY). 2022. PMID: 35085103 Free PMC article.

2

JAM2 predicts a good prognosis and inhibits invasion and migration by suppressing EMT pathway in breast cancer.

Peng Y, Li H, Fu Y, Guo S, Qu C, Zhang Y, Zong B, Liu S. Peng Y, et al. Among authors: li h. Int Immunopharmacol. 2022 Feb;103:108430. doi: 10.1016/j.intimp.2021.108430. Epub 2021 Dec 17. Int Immunopharmacol. 2022. PMID: 34923424

3

Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients.

Xu Y, Peng Y, Shen M, Liu L, Lei J, Gao S, Wang Y, Lan A, Li H, Liu S. Xu Y, et al. Among authors: li h. J Oncol. 2022 Apr 20;2022:1525245. doi: 10.1155/2022/1525245. eCollection 2022. J Oncol. 2022. PMID: 35498539 Free PMC article.

4

The Relationship Between Vitamin D and Activity of Daily Living in the Elderly.

Li H, Han D, Wang H, Shu D, Xu L, Hou L, Xu Y, Lai X. Li H, et al. Int J Gen Med. 2022 Aug 1;15:6357-6364. doi: 10.2147/IJGM.S366203. eCollection 2022. Int J Gen Med. 2022. PMID: 35935099 Free PMC article.

5

Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients.

Xu Y, Li H, Lan A, Wu Q, Tang Z, Shu D, Tan Z, Liu X, Liu Y, Liu S. Xu Y, et al. Among authors: li h. J Oncol. 2022 Sep 9;2022:2363043. doi: 10.1155/2022/2363043. eCollection 2022. J Oncol. 2022. PMID: 36117848 Free PMC article.

6

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy.

Shu D, Shen M, Li K, Han X, Li H, Tan Z, Wang Y, Peng Y, Tang Z, Qu C, Jin A, Liu S. Shu D, et al. Among authors: li h, li k. Ann Med. 2022 Dec;54(1):2581-2597. doi: 10.1080/07853890.2022.2122550. Ann Med. 2022. PMID: 36194178 Free PMC article.

7

MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer.

Li H, Li K, Shu D, Shen M, Tan Z, Zhang W, Pu D, Tan W, Tang Z, Jin A, Liu S. Li H, et al. Among authors: li k. Life (Basel). 2022 Sep 20;12(10):1461. doi: 10.3390/life12101461. Life (Basel). 2022. PMID: 36294896 Free PMC article.

8

Development and Assessment of a Novel Core Biopsy-Based Prediction Model for Pathological Complete Response to Neoadjuvant Chemotherapy in Women with Breast Cancer.

Lan A, Chen J, Li C, Jin Y, Wu Y, Dai Y, Jiang L, Li H, Peng Y, Liu S. Lan A, et al. Among authors: li c, li h. Int J Environ Res Public Health. 2023 Jan 16;20(2):1617. doi: 10.3390/ijerph20021617. Int J Environ Res Public Health. 2023. PMID: 36674372 Free PMC article.

9

Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy.

Lan A, Li H, Chen J, Shen M, Jin Y, Dai Y, Jiang L, Dai X, Peng Y, Liu S. Lan A, et al. Among authors: li h. J Pers Med. 2023 Jan 29;13(2):249. doi: 10.3390/jpm13020249. J Pers Med. 2023. PMID: 36836483 Free PMC article.

10

UTRN as a potential biomarker in breast cancer: a comprehensive bioinformatics and in vitro study.

Li H, Zhang W, Liu Y, Cai Z, Lan A, Shu D, Shen M, Li K, Pu D, Tan W, Liu S, Peng Y. Li H, et al. Among authors: li k. Sci Rep. 2024 Apr 2;14(1):7702. doi: 10.1038/s41598-024-58124-5. Sci Rep. 2024. PMID: 38565593 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121,759 results

Search Page

Filters